A detailed history of Virtu Financial LLC transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Virtu Financial LLC holds 19,103 shares of LVTX stock, worth $30,182. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,103
Holding current value
$30,182
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$1.57 - $2.29 $29,991 - $43,745
19,103 New
19,103 $32,000

Others Institutions Holding LVTX

About LAVA Therapeutics NV


  • Ticker LVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,797,700
  • Market Cap $40.8M
  • Description
  • LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...
More about LVTX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.